Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 1
1994 1
1995 1
1997 3
1998 2
2000 1
2001 1
2005 1
2006 1
2007 2
2008 1
2009 1
2014 1
2015 3
2018 1
2019 4
2020 2
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Results by year

Filters applied: . Clear all
Page 1
FUCCI-Red: a single-color cell cycle indicator for fluorescence lifetime imaging.
Shirmanova MV, Gorbachev DA, Sarkisyan KS, Parnes AP, Gavrina AI, Polozova AV, Kovaleva TF, Snopova LB, Dudenkova VV, Zagaynova EV, Lukyanov KA. Shirmanova MV, et al. Among authors: polozova av. Cell Mol Life Sci. 2021 Apr;78(7):3467-3476. doi: 10.1007/s00018-020-03712-7. Epub 2021 Feb 8. Cell Mol Life Sci. 2021. PMID: 33555392
Subvisible (2-100 μm) Particle Analysis During Biotherapeutic Drug Product Development: Part 1, Considerations and Strategy.
Narhi LO, Corvari V, Ripple DC, Afonina N, Cecchini I, Defelippis MR, Garidel P, Herre A, Koulov AV, Lubiniecki T, Mahler HC, Mangiagalli P, Nesta D, Perez-Ramirez B, Polozova A, Rossi M, Schmidt R, Simler R, Singh S, Spitznagel TM, Weiskopf A, Wuchner K. Narhi LO, et al. Among authors: polozova a. J Pharm Sci. 2015 Jun;104(6):1899-1908. doi: 10.1002/jps.24437. Epub 2015 Apr 1. J Pharm Sci. 2015. PMID: 25832583 Review.
Subvisible (2-100 μm) particle analysis during biotherapeutic drug product development: Part 2, experience with the application of subvisible particle analysis.
Corvari V, Narhi LO, Spitznagel TM, Afonina N, Cao S, Cash P, Cecchini I, DeFelippis MR, Garidel P, Herre A, Koulov AV, Lubiniecki T, Mahler HC, Mangiagalli P, Nesta D, Perez-Ramirez B, Polozova A, Rossi M, Schmidt R, Simler R, Singh S, Weiskopf A, Wuchner K. Corvari V, et al. Among authors: polozova a. Biologicals. 2015 Nov;43(6):457-73. doi: 10.1016/j.biologicals.2015.07.011. Epub 2015 Aug 29. Biologicals. 2015. PMID: 26324466 Review.
Multiparametric Optical Bioimaging Reveals the Fate of Epoxy Crosslinked Biomeshes in the Mouse Subcutaneous Implantation Model.
Elagin V, Kuznetsova D, Grebenik E, Zolotov DA, Istranov L, Zharikova T, Istranova E, Polozova A, Reunov D, Kurkov A, Shekhter A, Gafarova ER, Asadchikov V, Borisov SM, Dmitriev RI, Zagaynova E, Timashev P. Elagin V, et al. Among authors: polozova a. Front Bioeng Biotechnol. 2020 Feb 19;8:107. doi: 10.3389/fbioe.2020.00107. eCollection 2020. Front Bioeng Biotechnol. 2020. PMID: 32140465 Free PMC article.
PDA Biosimilars Workshop Report (September 27-28, 2018)-Getting It Right the First Time for Biosimilar Marketing Applications.
Krause S, Lacana E, Welch J, Shapiro M, Downey C, Chung J, Zhou Q, Van Der Plas M, Depatie C, Ingram B, Srebalus-Barnes C, Polozova A, Rellahan B, Choi D, Burdick R, Stangler T, Shacter E. Krause S, et al. Among authors: polozova a. PDA J Pharm Sci Technol. 2019 Jul-Aug;73(4):401-416. doi: 10.5731/pdajpst.2019.010215. Epub 2019 Apr 19. PDA J Pharm Sci Technol. 2019. PMID: 31004040
27 results